Nuvalent celebrates ALK Awareness Month as Nuvalent stock trades up to $92.08 amid weak momentum

Traders Union
All News
Companies
Nuvalent up 0.80% to $92.08 today

Highlights

NUVL trades decisively below major moving averages, confirming persistent bearish momentum across all timeframes.
Momentum and oscillator signals indicate an oversold condition, yet show little evidence of a trend reversal or buyer interest.
For the coming week, the forecasted range is $89.00 to $95.00, with further downside risk if support fails.

Sustained sell pressure as NUVL trades below major moving averages

NUVL is trading at $92.08, significantly below the SMA-20 ($102.77), SMA-50 ($102.76), and SMA-200 ($97.44), which confirms strong short-, medium-, and long-term pressure from sellers. The Ichimoku Kijun at $100.36 sits well above the current price and acts as immediate resistance; near-term support is at the SMA-200 ($97.44), with key support at the W1 SMA-100 ($88.49), while near-term resistance is the Ichimoku Kijun ($100.36) and key resistance is the SMA-20/SMA-50 cluster ($102.77).

Oversold conditions and stalled momentum amid sharp weekly decline

Momentum signals remain weak, with the MACD on D1 neutral at -1.50, and ADX D1 very low at 12.41, indicating an absence of a strong trend. Oversold readings from RSI D1 (34.62), Stoch RSI D1 (0.00), and CCI D1 (-299.78) highlight extreme downside exhaustion, while BBP D1 at -8.16 confirms dominant selling pressure. The AO D1 supports the downtrend with a strong sell signal. NUVL has fallen $18.31 (17.25%) from last week's close at $110.39 and is trading at the very bottom of the weekly range; weekly volatility stands at 24.97%, reflecting a sustained and sharp decline with little evidence of recovery.

Downside risk dominates as probability of rebound remains minimal

For the coming week, the expected price range is $89.00 to $95.00, keeping NUVL above its 52-week low of $71.13 and below the 52-week high of $113.02. The probability of a price increase is very low (less than 20%), making further downside more likely. Baseline scenario: the price consolidates between support at $89.00 and resistance near $95.00. A bullish scenario would require a sustained break above the Ichimoku Kijun ($100.36), opening the path toward $102.77. In a bearish scenario, a move below $89.00 could see NUVL retesting the $88.49 weekly SMA-100 area, approaching year-to-date lows.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that Nuvalent shares were trading within a consolidation phase following news of forthcoming clinical data releases for its ROS1+ NSCLC program. In light of ongoing market dynamics, investors should closely monitor shifts in sentiment around upcoming trial results as a potential catalyst for renewed price direction.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.